Stock Events

Stock Events

Dexcom 

€61.83
503
+€0.08+0.13% Monday 14:44

Statistics

Day High
61.83
Day Low
60.46
52W High
77.31
52W Low
47.59
Volume
39
Avg. Volume
-
Mkt Cap
24.11B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12FebExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.28
0.37
0.46
0.55
Expected EPS
0.55042295021
Actual EPS
N/A

Financials

14.29%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
7.66BRevenue
1.09BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1DXCM.MI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap945.97M
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap22.03B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap287.64M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap100.92B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap45.33B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Jacob Steven Leach
Employees
10200
Country
US
ISIN
US2521311074

Listings

MI
IT
1DXCM.MI
LSE
GB
0A4M.LSE
XETRA
DE
DC4.XETRA
XNAS
US
DXCM

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of 1DXCM.MI is €61.83 EUR — it has increased by +0.13% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dexcom stocks are traded under the ticker 1DXCM.MI.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 24.11B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on February 12, 2026.
What were Dexcom earnings last quarter?▼
1DXCM.MI earnings for the last quarter are 0.53 EUR per share, whereas the estimation was 0.5 EUR resulting in a +5.85% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 7.66B EUR.
What is Dexcom net income for the last year?▼
1DXCM.MI net income for the last year is 1.09B EUR.
How many employees does Dexcom have?▼
As of February 03, 2026, the company has 10,200 employees.
In which sector is Dexcom located?▼
Dexcom operates in the Health Care sector.
When did Dexcom complete a stock split?▼
Dexcom has not had any recent stock splits.
Where is Dexcom headquartered?▼
Dexcom is headquartered in San Diego, US.